MediciNova
MNOV
55 hedge funds and large institutions have $35.8M invested in MediciNova in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 23 closing their positions.
3% more call options, than puts
Call options by funds: $338K | Put options by funds: $329K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.97% less ownership
Funds ownership: 24.21% → 17.25% (-7%)
8% less funds holding
Funds holding: 60 → 55 (-5)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
40% less capital invested
Capital invested by funds: $59.4M → $35.8M (-$23.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.93M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$2.04M |
| 3 |
E
Ergoteles
New York
|
+$764K |
| 4 |
HF
HRT Financial
New York
|
+$520K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$398K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$9.73M |
| 2 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
-$2.52M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.44M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.58M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.47M |
MNOV Hedge Fund Activity: Q2 2021 in Review
55 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2021, worth a combined $35.8M — down 40% from $59.4M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of MNOV and 18 opened new positions — a net loss of 5 holders — while 19 trimmed existing stakes and 13 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $2.93M. The largest seller was BlackRock, cutting an estimated $9.73M.
- 55 institutional investors held MediciNova (MNOV) as of Q2 2021, down from 60 in Q1 2021.
- Funds reported $35.8M of MediciNova stock for Q2 2021, down 40% quarter-over-quarter.
- 18 funds opened new MediciNova positions in Q2 2021 and 23 closed out, a net change of -5 holders.
- The largest MediciNova buyer in Q2 2021 was Millennium Management, an estimated $2.93M added.
- The largest MediciNova seller in Q2 2021 was BlackRock, an estimated $9.73M sold.
Based on aggregated 13F filings for Q2 2021.